TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01172418

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Description: Alemtuzumab used as part of combined Induction.
Study: NCT00830154

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pagoclone
Description: 0.30 mg BID, 0.60 mg BID

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT01754597

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peptide Natriurétique de type B
Description: Peptide Natriurétique de type B
Study: NCT02533687

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar TURP-1
Description: Bipolar transurethral resection of prostate (TURP)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar TURP-2
Description: Bipolar TURP

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Monopolar TURP
Description: Monopolar TURP
Study: NCT01670136

Intervention type: DRUG
Group type: OTHER
Intervention: 1 dose of sildenafil
Description: A single IV dose of sildenafil will be administered over 90 minutes with no greater than a 15-minute flush. Final dose to be determined based on at least the first 4 participants enrolled in Cohort 1; final dose expected to be a single dose between 0.25 and 0.5 mg/kg.
Study: NCT01778270

Intervention type: DEVICE
Group type: OTHER
Intervention: Body Bioimpedance Sensor

Intervention type: DEVICE
Group type: OTHER
Intervention: Body Bioimpedance Sensor
Study: NCT02794623

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tinnitus masking
Description: Tinnitus masking via CI system
Study: NCT03199508

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: the 3-day voiding diary
Description: The 3-day voiding diary is a medical record which need participants to fill in a table about urine volume for 2 days and 3 nights.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: the 7-day voiding diary
Description: The 7-day voiding diary is a medical record which need participants to fill in a table about urine volume and drinking water volume for 4 days and 7 nights.
Study: NCT02855138

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oral isotretinoin
Study: NCT01573403

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS2411
Description: 1 caplet of DLBS2411 @250 mg and 1 placebo caplet, once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS2411
Description: 2 caplets of DLBS2411 @250 mg, once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo DLBS2411
Description: 2 placebo caplets of DLBS2411, once daily
Study: NCT04081662

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: compACT Intervention
Description: The mobile intervention in this study consists of two components: 1) self-monitoring and 2) an ACT-based microintervention.~Self-monitoring: twice daily, participants will complete self-reports of distress, depressive symptoms, and activity through the mobile app Lorevimo.~Microintervention: The microintervention will consist of one of 84 prompts that aim to target one of 6 processes targeted in ACT (contacting the present moment, defusion, acceptance, self-as-context, values, and committed action). At each time-point, participants have a 50% chance of receiving a microintervention question along with the daily self-monitoring assessments.
Study: NCT02646137

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation combined with TACE
Description: Radiofrequency ablation (RFA) is an alternative therapy for HCC and liver metastases that can destroy a tumor by inducing thermal injury to the tissue through electromagnetic energy deposition

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microwave ablation combined with TACE
Description: Microwave ablation (MWA) is an appealing alternative therapy for HCC in which a microwave antenna is placed directly into the tumor, emitting an electromagnetic wave which agitates water molecules in the surrounding tissue, producing friction and heat, thereby inducing cell death via coagulation necrosis
Study: NCT06004297

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ACL reconstruction
Description: performed arthroscopically

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ACL reconstruction
Description: performed arthroscopically

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction
Description: performed arthroscopically
Study: NCT03197610

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: enamel matrix derivatives
Description: enamel matrix derivatives and subepithelial connective tissue grafts

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: enamel matrix derivatives
Description: enamel matrix derivatives and subepithelial connective tissue grafts
Study: NCT02477527

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Stribild
Description: Change subjects from Atripla one tablet per day to elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil one tablet per day.
Study: NCT02003443

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Administered Acupressure
Description: The intervention involves teaching and supporting subjects to administer acupressure on themselves.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Self-Administered Acupressure
Description: The intervention involves teaching and supporting subjects to administer acupressure on themselves.
Study: NCT02414516

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OBP-801
Description: OBP-801 will be administered IV
Study: NCT01149330

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adapalene-BPO Gel
Description: Apply 1 gram of the investigational drug every night on whole face.
Study: NCT01119443

Intervention type: DRUG
Group type: OTHER
Intervention: PPX ER
Description: PPX ER 0.375mg - 1.5mg for 32 days totally

Intervention type: DRUG
Group type: OTHER
Intervention: PPX ER
Description: PPX ER 0.375mg - 1.5mg for 32 days totally
Study: NCT02529111

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Echonavigator software
Study: NCT02769429

Intervention type: DEVICE
Intervention: Ultrasound-guided CISB
Description: This group will receive ultrasound-guided CISB with the catheter placed on the upper trunk of the brachial plexus

Intervention type: DEVICE
Intervention: nerve stimulator-guided CCPVB
Description: This group will receive landmark with nerve stimulator based needle placement and then nerve stimulator-guided CCPVB with the catheter placed on the 6th cervical spinal root
Study: NCT02574559

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Developing Attention and Stability of Mind
Description: Completed at Week 1. Initial meditation exercises will be described and practiced to train attention skills (on breath) and create mental stability.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Cultivating Insight into the Nature of Mental Experience
Description: Completed at Week 2. Exercises to develop mindfulness will continue in order to promote mental stability and clarity.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Self-compassion
Description: Completed at Week 3: Techniques to analyze mental processes are introduced.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Cultivating Equanimity
Description: Completed at Week 4. Further analysis of mental processes.
Study: NCT03162991

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Intervention
Description: Aerobic Exercise Intervention- 12-weeks, exercise 3 non-consecutive days/week for \~30-55 minutes per exercise session.
Study: NCT01394432

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCI and Stem Cells or Placebo injections
Description: Conventional percutaneous coronary intervention after acute myocardial infarction. Harvest of bone marrow from iliac crest. Mesenchymal autologous stem cells preparation (7-10 days after PCI). LV mapping with Noga system (7-10 days after PCI). Randomization 1:1. Stem Cells or placebo implantation.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: PCI and Stem Cells or Placebo injections
Description: Conventional percutaneous coronary intervention after acute myocardial infarction. Harvest of bone marrow from iliac crest. Mesenchymal autologous stem cells preparation (7-10 days after PCI). LV mapping with Noga system (7-10 days after PCI). Randomization 1:1. Stem Cells or placebo implantation.
Study: NCT02794038

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Soberlink Cellular Device
Description: BAC breath analyzer

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BACtrack S80 Pro
Description: BAC breath analyzer
Study: NCT00969917

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPI-504
Description: IPI 504 administered twice weekly at 225 mg/m2 for 2 weeks followed by 1 week off treatment
Study: NCT03856892

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Dose Yoga
Description: Participants engage in an intensive full yoga practice of hatha breath-based practices and inner meditative techniques along with body-based asana. Intensive level uses breath, management of abdomen, inner focus in all practices. The high dose of yoga is an interpretation of the Translational Model of Yoga (TMY) and Yoga Process formula, both developed in this study's cultural research: a systematized psycho-physical yoga method of Hatha Zone (HZ) focus (below-navel, exhale, inner focus), incorporating key components of practice-focus-surrender (PFS) approach and repeat-engage-trust (RET) elements.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medium Dose Yoga
Description: The medium dose of yoga is a regular practice of primarily body-posture training with minimal reference to the breath, but with a longer period of time duration in training prior to intervention commencement. Participants have 5 months of pre-training before initiating the intervention.
Study: NCT01628575

Intervention type: PROCEDURE
Intervention: PAO
Description: all patients underwent periodontal surgery for bone decortication followed by orthodontic treatment
Study: NCT02581670

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic radiation therapy (SRT)
Description: Lung and liver stereotactic radiation therapy (SRT) in oligometastatic breast cancer patients unsuitable for surgery, using VMAT RapidArc approach
Study: NCT01248403

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel 80 mg/m2 on day 1, day 8 and day 15 of every 28-day cycle.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Paclitaxel 80 mg/m2 on day 1, day 8 and day 15 of every 28-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAD001
Description: RAD001 10mg (2 x5 mg tablets / day) d1-d28
Study: NCT02966353

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ruxolitinib
Description: Ruxolitinib was supplied in 5 mg tablets to be taken orally approximately 12 hours apart (morning and night)
Study: NCT00855569

Intervention type: DEVICE
Intervention: Stasilon
Description: Stasilon and gauze will be applied to donor site. Dressings will be collected and evaluated for amount of shed blood.
Study: NCT03112395

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pio Medical Device
Description: The Pio device combines the technologies of pulse modulated magnetic fields and light emission locally applied to the wound area.
Study: NCT02568163

Intervention type: OTHER
Group type: OTHER
Intervention: Non surgical periodontal treatment
Study: NCT00611611

Intervention type: BIOLOGICAL
Intervention: fluzone
Description: once

Intervention type: BIOLOGICAL
Intervention: fluzone
Description: once

Intervention type: BIOLOGICAL
Intervention: pneumovax
Description: once

Intervention type: BIOLOGICAL
Intervention: pneumovax
Description: once
Study: NCT02677532

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: 1 g every 8 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: 1 g every 8 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levobupivacaine wound infiltration
Description: Wound infiltration with 10 ml levobupivacaine 0.5%
Study: NCT03277625

Intervention type: PROCEDURE
Intervention: modified omega-shaped single-loop
Description: A double-layer, end-to-side, duct-to-mucosa PJ using interrupted polydioxanone 5-0 suture (PDS II, Ethicon, Somerville, USA) for the outer layer and interrupted polypropylene 5-0 suture (Prolene, Ethicon, USA) for the inner layer is the standard technique during PD at our Institution. For the modified omega-shaped single-Loop reconstruction the loop between PJ and HJ is left intentionally longer at about 25-30 cm and an additional side-to-side jejunojejunal anastomosis is performed at the lowest point between the afferent and efferent loops of the HJ This intestinal anastomosis is done in a double-layer continuous PDS 5-0 suture technique. Neither sealants, nor stents are being applied at the PJ. In cases of thin walled and tiny hepatic ducts, the HJ is splinted using an externally diverted T-tube.
Study: NCT02677532

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine epidural bolus
Description: Epidural bolus of 10 ml 0.25% levobupivacaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sufentanil epidural bolus
Description: Epidural bolus of 0.15 mcg/kg sufentanil

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Intravenous slow bolus of 10 mg morphine
Study: NCT01172418

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daclizumab
Description: Daclizumab used as part of combined induction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thymoglobulin
Description: Thymoglobulin used as part of combined induction.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thymoglobulin
Description: Thymoglobulin used as part of combined induction.
Study: NCT01213914

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: An FDA approved continuous renal replacement device
Description: 70ml/kg/hr for treatment group for 48 hours with the following requirements:~* double lumen dialysis catheter should be placed in the internal jugular or femoral vein~* Anticoagulation will be determined by prescribing physician~* Use of 1.4 m2 or larger biocompatible synthetic hollow-fiber dialysis membrane that is changed every 24 hours~* Blood flow rate will be set to ensure a filtration fraction of no more than 25%~* Monitoring for electrolytes (specifically K+, Mg, Ca, and phos) during HVHF must be performed at least every 6 hours~* Replacement fluids will be bicarbonate-buffered with appropriate adjustments when citrate-anticoagulation is utilized~* All antibiotics will be dose adjusted for renal replacement therapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Both groups will receive 'contemporary' care via consideration of the Burn-specific Sepsis Bundle adapted from the most recent Surviving Sepsis Campaign (SSC) (1) recommendations and specifically modified to our patient population
Study: NCT00979108

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy rehabilitation
Description: Mechanical cervical traction will be applied at a moderate force and adjusted based on symptom relief. In addition, subjects will be trained in cervical and postural exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy rehabilitation
Description: Subjects will be instructed in use of an over-the-door traction unit utilizing weights up to 20 pounds in sitting. In addition, subjects will be trained in neck and postural exercises.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical therapy rehabilitation
Description: Subjects will be instructed in neck and postural exercises.
Study: NCT00801892

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Description: Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham- Continuous Positive Airway Pressure (Sham-CPAP)
Description: Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).
Study: NCT02574559

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Developing Appreciation and Gratitude for Others
Description: Completed at Week 5. A reflection of all the things that bring us well-being are provided by or dependent upon other beings is encouraged.
Study: NCT04150354

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cogito Companion
Description: During the course of the study, the research application (Cogito Companion) will be installed on participants' mobile phone. The application on the participants' phone will be recording data about their behavior. Participants will also be asked to complete bi-weekly surveys via the app.
Study: NCT01521806

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary Fiber
Description: Dietary fiber will be added to snack foods

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary Fiber
Description: Dietary fiber will be added to snack foods

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Dietary Fiber
Description: Dietary fiber will be added to snack foods
Study: NCT01273987

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: rONB
Description: Neobladder posterior wall suspended with round ligament of uterus after radical cystectomy in female with bladder cancer
Study: NCT03177967

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy/Stimulus Control
Description: Sleep Restriction Therapy focuses on forcing your available sleep time into a fixed window. The sleeper sets a bedtime and wake-up time and sticks to those times closely. The time allocated for being allowed in bed is determined from an estimate of how long the patient in average has been sleeping during the night, in the week before treatment. The goal is to have the patient sleeping the entire time he or she is in bed by making this period so restricted that the patient has no chance of sleeping enough. Once this goal is achieved, the time allocated for bed can be slowly increased, for example by 15 minutes at a time. After enough iterations, an equilibrium is achieved that the patient can keep maintaining after treatment has completed.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy/Stimulus Control
Description: Sleep Restriction Therapy focuses on forcing your available sleep time into a fixed window. The sleeper sets a bedtime and wake-up time and sticks to those times closely. The time allocated for being allowed in bed is determined from an estimate of how long the patient in average has been sleeping during the night, in the week before treatment. The goal is to have the patient sleeping the entire time he or she is in bed by making this period so restricted that the patient has no chance of sleeping enough. Once this goal is achieved, the time allocated for bed can be slowly increased, for example by 15 minutes at a time. After enough iterations, an equilibrium is achieved that the patient can keep maintaining after treatment has completed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discussions about adverse cognitions about sleep
Description: Group discussions about insomnia, CBT-i treatment and it's effects

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discussions about adverse cognitions about sleep
Description: Group discussions about insomnia, CBT-i treatment and it's effects

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducative advice about how to improve sleep
Description: Learning about sleep and sleep hygiene tips. It also includes learning about stimulus control and sleep restriction.
Study: NCT01610908

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Schroth exercises treatment
Description: The Schroth approach consists of 3D scoliosis-specific exercises based on sensorimotor and kinesthetic principles. The goal of Schroth exercises is to teach patients to consciously maintain the correct posture in daily living activities in order to improve the curve, pain, and self-image. To achieve this goal, Schroth exercises focus on endurance and strength training of postural muscles. Schroth exercises also aim to improve posture motor control by repeating corrective movements with progressively less feedback and less passive support.~Dosage: 5 individual 1-hour long sessions, continued with the daily 45 minutes home exercise program. In addition, patients are required to come weekly for 1-hour long group sessions over the span of 6 months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Global Postural Re-Education
Description: The 6-month supervised Global Postural Re-education intervention involves active movements and postures aimed at realigning joints, stretching shortened muscles and enhancing the contraction of antagonist muscles, thus avoiding postural asymmetry. These postures imply an active participation of the patient. Global Postural Re-education includes eight therapeutic postures, lying, sitting or standing, held for 15/20 min. each. Variously combinations are used during sessions chosen on based on the amount of pain, load capacity, age of the patient, and muscle chains to be stretched. Static and dynamic functions are also employed for about five minutes each sessions to use the recovered flexibility in functional activities Dosage: Weekly individual 1-hour long sessions, with daily 15 minutes home exercise program over 6 months.